The lack of correlation between symptoms and signs in patients with meibomian gland dysfunction: a secondary analysis of the multicenter, randomized controlled trial

Table 5 Regression analysis between SPEED score and different influencing factors in women

	Age		Menopause (no = 0, yes = 1)		Region (north = 0, south = 1)
	Regression coefficient	p	Regression coefficient	p	Regression coefficient	p
SPEED	0.063	0.267	-4.112	0.025*	-2.080	0.067
TBUT	0.021	0.204	-0.490	0.350	-0.031	0.926
CFSS	0.006	0.809	0.475	0.522	0.563	0.226
MGYSS	-0.071	0.088	2.410	0.072	0.792	0.339
Lid margin hyperemia	0.001	0.975	-0.270	0.835	-3.125	< 0.0001*
Lid margin thickening	0.070	0.023*	-0.283	0.734	-2.086	0.003*
Lid margin rounding	0.135	0.001*	-1.359	0.159	-20.909	0.997
Hyperkeratinization	0.089	0.010*	-0.958	0.284	-2.800	0.010*
Telangiectasia around orifices	0.026	0.314	0.424	0.585	-0.549	0.292

SPEED Standard patient evaluation of eye dryness, TBUT Tear break-up time, CFSS Corneal fluorescein staining score, MGYSS Meibomian gland yielding secretion score
^* p < 0.05

ISSN: 1471-2415